Cultivated Meat & Seafood
Efishient Protein announces successful development of tilapia cell line

Phoebe Fraser
12 April 2024
12 April 2024
Efishient Protein announces successful development of tilapia cell line

Israeli food-tech company Efishient Protein has announced the successful completion of its talapia cell line development.
Through its technological capabilities, Efishient Protein has unlocked the potential to produce muscle and fat cells of tilapia, which it says is a ‘key step towards establishing a genetic cell bank’.
Dana Levin, CEO of Efishient Protein, said: "We are thrilled to lead the way in revolutionising the global fish products industry. Completing the tilapia cell line development showcases our dedication to accelerating sustainable protein solutions, ensuring future generations can enjoy nutritious and ethical fish products".

Efishient Protein recognises that its partnership with BioMeat Foodtech and the Volcani Institute was instrumental in this latest achievment, combining the companies' tech with their experience in the alt-protein sector.
#EfishientProtein #Israel
Related news
Wanda Fish names new CEO as Heffetz transfers to active vice chairman
Wanda Fish has announced that its co-founder and CEO Daphna Heffetz has stepped down after more than three years at the helm.
Forsea achieves ‘record-breaking’ cell density for its cultivated seafood
Cultivated seafood start-up Forsea has made a breakthrough in its production of cultured freshwater eel.
Navigating the future: Key insights from FPP Amsterdam 2024
Navigating the future: Key insights from FPP Amsterdam 2024
Cultivated Meat & Seafood
Efishient Protein announces successful development of tilapia cell line

Phoebe Fraser
12 April 2024